Skip to content

Legal status · Canada

Is Trametinib legal in Canada?

Written by Reviewed Sep 2026

ApprovedLongevityNo human studies cited

Direct answer

Yes. Trametinib is an approved medicine in Canada, classified as "Health Canada approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, no human study is cited on its profile.

Trametinib in Canada at a glance

ClassificationHealth Canada approved, prescription only
Health Canada approval statusApproved by Health Canada for its labeled use
Human studies cited0 of 1 citations on the profile
ReviewedSep 2026

Classification and note come from the Trametinib profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.

What this means

  • 01

    Health Canada has approved Trametinib for at least one labeled indication, so a pharmaceutical-grade product exists in Canada and is dispensed on prescription.

  • 02

    Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.

  • 03

    Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.

What Trametinib is

An approved melanoma drug that extended mouse lifespan, and did so additively with rapamycin, which suggests the two pathways are separate levers rather than the same one.

Most compounds that extend lifespan in mice are thought to work through nutrient sensing, which means adding them together should produce little more than either alone. Trametinib is interesting because it appears not to fit that pattern.

Mechanism: A selective allosteric inhibitor of MEK1 and MEK2, the kinases immediately downstream of RAF in the Ras, RAF, MEK, ERK cascade. That cascade transmits growth factor signals to the nucleus and drives proliferation, and it is constitutively active in cancers with BRAF mutations, which is the basis of the approval.

Regulatory history: FDA-approved as Mekinist for BRAF-mutant melanoma and other BRAF-mutant cancers, usually combined with dabrafenib. Not approved for any ageing indication.

How Health Canada treats this kind of product

Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.

The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Trametinib at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Trametinib in other countries

Frequently asked questions

Is Trametinib legal in Canada?

Yes. Trametinib is an approved medicine in Canada, classified as "Health Canada approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, no human study is cited on its profile.

Can I buy Trametinib in Canada?

Only with a prescription. Trametinib is classified as "Health Canada approved, prescription only" in Canada, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.

Is Trametinib Health Canada approved?

Yes, for its labeled indication. In Canada Trametinib is classified as "Health Canada approved, prescription only". For comparison, the US FDA status is: FDA-approved as Mekinist for BRAF-mutant melanoma and other BRAF-mutant cancers, usually combined with dabrafenib. Not approved for any ageing indication.. On the evidence, no human study is cited on its profile.

Related compounds in Canada

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for Trametinib live on its compound profile.

Trametinib profile

This page is general information about the regulatory status of Trametinib in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.